This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Background Despite limited beneficial evidence, mechanical circulatory support (MCS) is commonly used in patients with acute myocardialinfarction-related cardiogenicshock (AMI-CS). In this Dutch registry, we investigated MCS usage, associated patient characteristics and clinical outcomes.
Background Cardiogenicshock (CS) induced by severe aortic stenosis (AS) is a life-threatening condition with high mortality. In-hospital mortality pooled estimated rates were 11% for eTAVI (CI 0.06 - 0.18) and for eBAV 40% (CI 0.28 - 0.54). Methods A systematic literature review and meta-analysis was performed.
This case report describes a unique instance of a patient developing AEF following AF ablation, accompanied by ischemic stroke and myocardialinfarction. Upon admission, physical examination and laboratory tests revealed vital signs within abnormal ranges and indicators suggesting inflammation and potential myocardial injury.
Impella and venoarterial extracorporeal membrane oxygenation (VA-ECMO) in patients with acute myocardialinfarction-related cardiogenicshock (AMICS). Impella patients were older (34% vs. 13% >75 years, p < 0.001) and less frequently presented after an out-of-hospital cardiac arrest (18% vs. 40%, p < 0.001).
BackgroundAcute myocardialinfarction complicated by cardiogenicshock (AMI‐CS) is associated with significant morbidity and mortality. The primary end point was in‐hospital mortality. Survival rates to hospital discharge were high. A total of 406 patients were enrolled at 80 sites between 2016 and 2020.
In a seminal case series published in 1967, Killip and Kimball reported 81% in-hospital mortality for patients presenting with acute myocardialinfarction complicated by cardiogenicshock (AMI-CS).
The International Registry of MitraClip in Acute Mitral Regurgitation following Acute MyocardialInfarction (IREMMI). Methods and results The International Registry of MitraClip in Acute Mitral Regurgitation following Acute MyocardialInfarction (IREMMI) includes 187 patients with severe MR post-MI managed with TEER.
She presented to an outside hospital after several days of malaise and feeling unwell. This is a value typical for a large subacute MI, n ormal value 48 hours after myocardialinfarction is associated with Post-Infarction Regional Pericarditis ( PIRP ). PIRP is strongly associated with myocardial rupture.
Publication date: Available online 5 April 2024 Source: The American Journal of Cardiology Author(s): Amit Saha, Shuang Li, James A. de Lemos, Ambarish Pandey, Deepak L. Bhatt, Gregg C. Fonarow, Brahmajee K. Nallamothu, Tracy Y.MHS WangMSc, Ann Marie Navar, Eric Peterson, Roland A. Matsouaka, Anthony A. Bavry, Sandeep R. Das, Justin L.
BackgroundCardiogenic shock complicating acute myocardialinfarction is associated with a high mortality rate. Cardiogenicshock after outofhospital cardiac arrest (OHCA) can be due to transient myocardial stunning but also reflect the increasing severity of ongoing heart failure.
Secondary outcomes included in-hospital and 30-day events. vs 3.9%, p<0.001) and ST-elevation myocardialinfarction (59.1% vs 50.8%, p<0.001) and were more likely to experience postprocedural cardiogenicshock (4.5% Methods We analysed data from the Melbourne Interventional Group PCI Registry.
This analysis included 17 843 admissions across 34 sites and compared interhospital tertiles of CCRx (eg, mechanical ventilation, mechanical circulatory support, continuous renal replacement therapy) utilization and its adjusted association with in-hospital survival using logistic regression.
Post-procedural data included average length of in-hospital stay, intra-hospital morbidity and mortality, and mortality or admission with ACS 12–36 months after the index procedure. A total of 567 patients underwent coronary catheterisation for the three-year period between January 2018 and December 2020.
Author continued : STE in aVR is often due to left main coronary artery obstruction (OR 4.72), and is associated with in-hospital cardiovascular mortality (OR 5.58). Authors' commentary: Cardiogenicshock in the setting of severe aortic stenosis. Fundamentally, cardiogenicshock is an issue of decreased cardiac output.
BackgroundPatients with severe mitral regurgitation and cardiogenicshock demonstrate a poor prognosis. The primary outcome was device success and allcause death, while secondary outcomes included myocardialinfarction, stroke, and heart failure hospitalization rates at 30day and intermediateterm followup.
New insights into the use of the 12-lead electrocardiogram for diagnosing acute myocardialinfarction in the emergency department. An elderly man with sudden cardiogenicshock, diffuse ST depressions, and STE in aVR Literature 1. 2 cases of Aortic Stenosis: Diffuse Subendocardial Ischemia on the ECG. Left main?
Organ perfusion pressure as a predictor of outcomes in cardiogenicshock: insights from the Altshock-2 registry. ABSTRACT Aims The diagnosis of cardiogenicshock (CS) relies upon signs and/or symptoms of end-organ hypoperfusion. The primary outcome was in-hospital all-cause mortality. Low OPP (i.e. <57.0mmHg)
Henry Ford Health's National CardiogenicShock Initiative research team. Cardiogenicshock is a critical condition in which the heart is unable to pump enough blood to sustain the body’s needs, depriving vital organs of blood supply. This can cause those organs to eventually stop functioning.
BACKGROUND:There are limited large-scale data on the outcomes of patients with cardiogenicshock (CS) transferred to hub centers. Overlap propensity score weighting was performed to assess the association between transfer status and in-hospital mortality. In-hospital mortality was lower in transferred patients39.1%
BACKGROUND:In patients with ST-segment–elevation myocardialinfarction complicated by cardiogenicshock, primary percutaneous coronary intervention (pPCI) is the preferred revascularization option. pharmacoinvasive and 46.2% pharmacoinvasive and 46.2% The incidence of the primary safety outcome was 10.1% 1.09];P=0.08).CONCLUSIONS:In
IntroductionIn developing countries, there is a notable scarcity of real-world data on adherence to optimal medical therapy (OMT) and its correlation with major cardiovascular adverse events (MACEs) after ST-elevation myocardialinfarction (STEMI). Patients were followed up for 4.5 ResultsWe included 349 patients with a mean age of 58.08
Predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in patients with cardiogenicshock. The cause of CS was acute myocardialinfarction in 438 (63.9%) patients, and 431 (62.9%) patients presented with cardiac arrest. RRT, renal replacement therapy. interquartile range 4.112.7]
Abstract Objectives This study aimed to assess the impact of anemia and iron deficiency (ID) on clinical outcome in patients with cardiogenicshock (CS) complicating acute myocardialinfarction (AMI). ID has no relevant impact on clinical outcome in patients with CS.
Acute myocardialinfarction–related cardiogenicshock (AMI-CS) is characterized by systemic hypoperfusion due to cardiomyocyte necrosis and ventricular dysfunction.1 2 Prompt reperfusion.
There is limited understanding of race differences in the management and outcomes of CS.Methods:We queried the US National Inpatient Sample database (years 2016-2021) for CS hospitalizations in adults and categorized them by presence of acute myocardialinfarction (AMI) on admission. 0.93), pLVAD (aOR: 0.79, 95%CI: 0.72-0.86),
BackgroundPatients hospitalized with COVID19 from socioeconomically vulnerable communities are at risk for inhospital cardiovascular events. ConclusionsAmong survivors of COVID19 hospitalization, patientlevel social vulnerability was associated with cardiovascular events, explained by increased comorbidities.
INTRODUCTION:Percutaneous coronary intervention for complex coronary disease is associated with a high risk of cardiogenicshock. Cardiogenicshock and acute ST-segment–elevation myocardialinfarction are exclusions. Circulation: Cardiovascular Interventions, Ahead of Print.
BACKGROUND:Patients with ST-segment–elevation myocardialinfarction but no coronary microvascular injury are at low risk of early cardiovascular complications (ECC). Discharging patients with NH-IMRangio<40 units at 48 hours after admission would reduce the total in-hospital stay by 943 days (median 2 [1–4] days per patient).CONCLUSIONS:NH-IMRangiois
Background Takotsubo cardiomyopathy (TC) is an established differential diagnosis of myocardialinfarction with non-obstructive coronaries with significant interest but limited data on prognostication. We reviewed the characteristics and in-hospital outcomes and developed a novel risk score for TC. to 1.66), p<0.001).
milla1cf Mon, 04/08/2024 - 18:07 April 8, 2024 — Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly increased the rate of survival at six months among people suffering cardiogenicshock, according to a study presented at the American College of Cardiology ’s Annual Scientific Session.
Assessment was severe sudden cardiogenicshock. Clin Chem [Internet] 2020;Available from: [link] Smith mini-review: Troponin in Emergency Department COVID patients Cardiac Troponin (cTn) is a nonspecific marker of myocardial injury. MyocardialInfarction Type 2 and Myocardial Injury. What is it?
The patient in today’s case presented in cardiogenicshock from proximal LAD occlusion, in conjunction with a subtotally stenosed LMCA. Troponin T peaked at 38,398 ng/L ( = a very large myocardialinfarction, but not massive-- thanks to the pre-PCI spontaneous reperfusion, and rapid internvention!! ).
LAD 80% mid LCx occluded mid (acute infarct lesion) RCA 80% mid. PCI mid LCx So this is an OMI (Occlusion MyocardialInfarction), but not a STEMI Echo: Decreased left ventricular systolic performance, mild/moderate. The patient went into cardiogenicshock and ultimately died of this MI. The cath lab was activated.
At the bottom of the post, I have re-printed the section on aVR in my article on the ECG in ACS from the Canadian Journal of Cardiology: New Insights Into the Use of the 12-Lead Electrocardiogram for Diagnosing Acute MyocardialInfarction in the Emergency Department Case 1. Widimsky P et al. O'Gara PT, Kushner FG, Ascheim DD, et al.
This pattern is essentially always accompanied by cardiogenicshock and high rates of VT/VF arrest, etc. The patient arrived to the ED in cardiogenicshock but awake. in-hospital mortality was 18.8% With so much STD in leftward and inferior leads V4-V6, II, III, and aVF, of course there must be STE in aVR.
Why is the patient in shock? He was in profound cardiogenicshock. The patient never arrested during his time at the hospital and his prognosis is good. Posterior wall involvement attenuates predictive value of ST-segment elevation in lead V4R for right ventricular involvement in inferior acute myocardialinfarction.
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)
When one of these arteries becomes completely blocked by a blood clot, it results in a heart attack, also known as MI (Myocardialinfarction). When a person experiences a heart attack or myocardialinfarction, they may feel chest pain and other symptoms in different parts of their body.
Methods A large-scale cohort study of patients with ST-elevation/non-ST-elevation myocardialinfarction (MI)/unstable angina underwent coronary angiography (January 2015–December 2019). Older patients had a greater risk of in-hospital mortality than younger patients (adjusted OR (aOR) 2.12, 95% CI 1.62 to 1.10, p=0.684).
BackgroundCardiogenic shock (CS) is a severe complication of acute myocardialinfarction (AMI) with high mortality. Primary outcomes explored the correlation between vasoactive use and in-hospital mortality. had ST-segment elevation myocardialinfarction. Clinical and 24h hemodynamic data were analyzed.
1) as far as I can tell, there is very little data on amiodarone for this indication 2) amiodarone has beta blockade effects which could be deleterious in a patient with large anterior MI with pulmonary edema and at risk for cardiogenicshock (and she did go into shock. DOI: 10.1016/j.resuscitation.2025.110515
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content